Page last updated: 2024-08-24

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and EHS Tumor

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine has been researched along with EHS Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzarini, J; De Clercq, E; Holy, A; Naesens, L; Neyts, J; Rosenberg, I1
Balzarini, J; De Clercq, E; Naesens, L1

Other Studies

2 other study(ies) available for 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and EHS Tumor

ArticleYear
Efficacy of oral 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the treatment of retrovirus and cytomegalovirus infections in mice.
    Journal of medical virology, 1993, Volume: 39, Issue:2

    Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Cytomegalovirus Infections; Friend murine leukemia virus; Injections, Intraperitoneal; Leukemia, Experimental; Mice; Moloney murine sarcoma virus; Sarcoma, Experimental; Survival Rate; Treatment Outcome

1993
Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo.
    Antiviral research, 1991, Volume: 16, Issue:1

    Topics: Adenine; Animals; Animals, Newborn; Antiviral Agents; Cell Line; Cell Transformation, Viral; Drug Administration Schedule; Injections, Intraperitoneal; Mice; Moloney murine sarcoma virus; Organophosphonates; Sarcoma, Experimental

1991